0001237899-20-000015.txt : 20200403 0001237899-20-000015.hdr.sgml : 20200403 20200403160551 ACCESSION NUMBER: 0001237899-20-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200401 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenimore Christopher R. CENTRAL INDEX KEY: 0001697422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20773351 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-04-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001697422 Fenimore Christopher R. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller Common Stock 2020-04-01 4 M 0 1200 30.63 A 14297 D Common Stock 2020-04-01 4 S 0 63 478.77 D 14234 D Common Stock 2020-04-01 4 S 0 69 479.0 D 14165 D Common Stock 2020-04-01 4 S 0 58 480.28 D 14107 D Common Stock 2020-04-01 4 S 0 62 482.09 D 14045 D Common Stock 2020-04-01 4 S 0 124 483.58 D 13921 D Common Stock 2020-04-01 4 S 0 3 484.14 D 13918 D Common Stock 2020-04-01 4 S 0 137 488.76 D 13781 D Common Stock 2020-04-01 4 S 0 201 489.48 D 13580 D Common Stock 2020-04-01 4 S 0 70 491.65 D 13510 D Common Stock 2020-04-01 4 S 0 134 492.45 D 13376 D Common Stock 2020-04-01 4 S 0 174 493.24 D 13202 D Common Stock 2020-04-01 4 S 0 37 494.16 D 13165 D Common Stock 2020-04-01 4 S 0 68 497.99 D 13097 D Common Stock 1401 I By 401(k) Plan Common Stock 1897 I By Trust Common Stock 509 I by 2017 GRAT Common Stock 2284 I by 2018 GRAT Incentive Stock Option (right to buy) 30.63 2020-04-01 4 M 0 1200 0.0 D 2020-12-14 Common Stock 1200 2180 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 124 shares of Company stock on April 1, 2020 at prices ranging from $483.35 to $483.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 137 shares of Company stock on April 1, 2020 at prices ranging from $488.57 to $488.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 201 shares of Company stock on April 1, 2020 at prices ranging from $489.17 to $489.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 134 shares of Company stock on April 1, 2020 at prices ranging from $492.07 to $492.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Represents volume-weighted average price of sales of 174 shares of Company stock on April 1, 2020 at prices ranging from $493.14 to $493.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**Christopher R. Fenimore 2020-04-02